سعر تكنوسبيرون 21 قرص 2024

Combined oral contraceptive containing ethinylestradiol 0.03 mg and drospirenone 3 mg per film-coated tablet, 21 tablets, by Technopharma.

• Prevention of pregnancy in females of reproductive potentialPopulation: Females of reproductive potentialDailyMed (U.S. National Library of Medicine)

• Most frequent (≥2%): premenstrual syndrome, headache/migraine, breast pain/tenderness, nausea/vomiting, abdominal pain, mood changes.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Renal impairment; adrenal insufficiency; high risk of arterial or venous thrombotic disease (e.g. smokers over 35, current or past DVT/PE, cerebrovascular or coronary artery disease, thrombogenic valvular/rhythm disease, hypercoagulopathies, uncontrolled hypertension), among others listed in the label.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use, especially in women over 35; women over 35 who smoke should not use it.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• No use for contraception in pregnancy; discontinue if pregnancy occurs. Epidemiologic studies have not found an increased risk of birth defects after exposure before conception or in early pregnancy.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Can reduce milk production in breast-feeding females.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Ethinylestradiol: As part of an estrogen-progestogen combination: inhibits ovulation by suppressing the mid-cycle LH surge, thickens cervical mucus and makes the endometrium unreceptive to implantation.
• Drospirenone: Binds progesterone receptors; antimineralocorticoid and antiandrogenic activity.